- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by NeuroEM Therapeutics, Inc.
Total 3039 results
-
Sorrento Therapeutics, Inc.CompletedMetastatic Breast Cancer | Locally Recurrent Breast CancerUnited States, Georgia, Moldova, Republic of, Romania, Serbia, Singapore, Ukraine
-
Opexa Therapeutics, Inc.TerminatedClinically Isolated Syndrome | Multiple Sclerosis, Relapsing-RemittingUnited States
-
INSYS Therapeutics IncCompleted
-
Topokine Therapeutics, Inc.Completed
-
Orexigen Therapeutics, IncCompleted
-
Onconova Therapeutics, Inc.TerminatedLymphoma | Acute Lymphocytic LeukemiaUnited States
-
INSYS Therapeutics IncCompletedPharmacokinetics and PharmacodynamicsUnited States
-
CymaBay Therapeutics, Inc.CompletedGoutUnited States, Canada, Georgia
-
Mirati Therapeutics Inc.TerminatedHodgkin's LymphomaUnited States, Canada
-
Mirati Therapeutics Inc.CompletedLymphocytic Leukemia, ChronicUnited States, Canada
-
Mirati Therapeutics Inc.CompletedLymphomaUnited States, Canada
-
PNP Therapeutics, Inc.CompletedHead and Neck CancerUnited States
-
Repros Therapeutics Inc.CompletedSecondary HypogonadismUnited States
-
Repros Therapeutics Inc.CompletedSecondary HypogonadismUnited States
-
Tobira Therapeutics, Inc.Completed
-
Cara Therapeutics, Inc.Completed
-
Mirati Therapeutics Inc.TerminatedAcute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)United States, Canada, United Kingdom
-
CymaBay Therapeutics, Inc.CompletedType 2 DiabetesUnited States, Israel, Argentina, India
-
Cara Therapeutics, Inc.CompletedAcute PainUnited States
-
Melinta Therapeutics, Inc.CompletedHepatic ImpairmentUnited States
-
CymaBay Therapeutics, Inc.CompletedHyperuricemia | GoutUnited States
-
Omnitura Therapeutics, Inc.Completed
-
CymaBay Therapeutics, Inc.CompletedHyperuricemia | GoutUnited States
-
Nivalis Therapeutics, Inc.CompletedHealthyUnited States
-
Mirati Therapeutics Inc.TerminatedStomach Cancer | Breast Cancer | Gastric Cancer | Lung Cancer | Prostate Cancer | Non-Small-Cell Lung Carcinoma | Prostatic Cancer | Pulmonary CancerUnited States
-
Orexigen Therapeutics, IncCompleted
-
Orexigen Therapeutics, IncCompletedObesity | OverweightUnited States
-
Orexigen Therapeutics, IncCompletedObesity | Diabetes Mellitus, Type 2 | OverweightUnited States
-
INSYS Therapeutics IncWithdrawn
-
Avalo Therapeutics, Inc.CompletedChronic Refractory CoughUnited States
-
Pearl Therapeutics, Inc.Completed
-
Repros Therapeutics Inc.CompletedEffect of Treatment on Bone Mineral DensityUnited States
-
Repros Therapeutics Inc.Completed
-
Repros Therapeutics Inc.Completed
-
Repros Therapeutics Inc.Terminated
-
Repros Therapeutics Inc.TerminatedRenal ImpairmentUnited States
-
Repros Therapeutics Inc.Terminated
-
Repros Therapeutics Inc.CompletedDrug InteractionsUnited States
-
Repros Therapeutics Inc.TerminatedUterine FibroidsUnited States
-
Repros Therapeutics Inc.TerminatedAnemia | Uterine FibroidsMexico
-
Repros Therapeutics Inc.TerminatedAnemia | Uterine FibroidsUnited States
-
Repros Therapeutics Inc.CompletedPharmacokinetics | TolerabilityUnited States
-
Repros Therapeutics Inc.Completed
-
Repros Therapeutics Inc.CompletedSecondary HypogonadismUnited States
-
Repros Therapeutics Inc.Completed
-
Repros Therapeutics Inc.CompletedSecondary HypogonadismUnited States
-
Repros Therapeutics Inc.CompletedUterine LeiomyomataPoland
-
Tarsa Therapeutics, Inc.CompletedPhase 1 Pharmacodynamic StudyUnited States
-
Revance Therapeutics, Inc.Terminated